sucralfate
sucralfate is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including sucralfate, Sucralfate oral suspension. Available dosage forms: suspension, tablet.
Drug details
- Generic Name
- sucralfate
- Brand Names
- sucralfate, Sucralfate oral suspension
- Application Number
- ANDA212913
- Sponsor
- Mylan Pharmaceuticals Inc.
- NDC Codes
- 5
- Dosage Forms
- SUSPENSION, TABLET
- Routes
- ORAL
- Active Ingredients
- SUCRALFATE
Indications and Usage
INDICATIONS AND USAGE Sucralfate is indicated in: • Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. • Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.